Hematological abnormalities in liver cirrhosis

doi:10.4254/wjh.v16.i9.1229

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1908)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

HTML

1506

Figures (1-4)

Tables (1-2)

Sum=1710

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=90

Sep 27, 2024 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Sep 27, 2024; 16(9): 1229-1246
Published online Sep 27, 2024. doi: 10.4254/wjh.v16.i9.1229

Full Size Figure Download Figure

Figure 3 Hemostatic balance in patients with chronic liver disease. Created with BioRender.com. TAFI: Thrombin-activatable fibrinolysis inhibitor; tPA: Tissue-plasminogen activator; PAI: Plasminogen activator inhibitor.

Citation: Fierro-Angulo OM, González-Regueiro JA, Pereira-García A, Ruiz-Margáin A, Solis-Huerta F, Macías-Rodríguez RU. Hematological abnormalities in liver cirrhosis. World J Hepatol 2024; 16(9): 1229-1246
URL: https://www.wjgnet.com/1948-5182/full/v16/i9/1229.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i9.1229